Home

Vana Prohlédnout Premiér apoa i Průmyslový náboženství doutník

Bovine apolipoprotein (apo)A-I displays more enhanced antioxidant and  anti-atherosclerotic activity in lipid-free and lipid-bound states than  human and porcine apoA-I
Bovine apolipoprotein (apo)A-I displays more enhanced antioxidant and anti-atherosclerotic activity in lipid-free and lipid-bound states than human and porcine apoA-I

Frontiers | ABCA1, apoA-I, and BTN3A1: A Legitimate Ménage à Trois in  Dendritic Cells
Frontiers | ABCA1, apoA-I, and BTN3A1: A Legitimate Ménage à Trois in Dendritic Cells

Apolipoprotein A-I (ApoA-I) Mimetic Peptide P2a by Restoring Cholesterol  Esterification Unmasks ApoA-I Anti-Inflammatory Endogenous Activity In Vivo  | Journal of Pharmacology and Experimental Therapeutics
Apolipoprotein A-I (ApoA-I) Mimetic Peptide P2a by Restoring Cholesterol Esterification Unmasks ApoA-I Anti-Inflammatory Endogenous Activity In Vivo | Journal of Pharmacology and Experimental Therapeutics

Thomas Dayspring on Twitter: "CLICK: Apolipoprotein A-I produced in  hepatocytes (most secreted, but some affixed to VLDL) or enterocytes (where  most affixes to chylomicrons) lipidates (with PL or FREE cholesterol) and  begins
Thomas Dayspring on Twitter: "CLICK: Apolipoprotein A-I produced in hepatocytes (most secreted, but some affixed to VLDL) or enterocytes (where most affixes to chylomicrons) lipidates (with PL or FREE cholesterol) and begins

Structural Determination of Lipid-bound ApoA-I Using Fluorescence Resonance  Energy Transfer - ScienceDirect
Structural Determination of Lipid-bound ApoA-I Using Fluorescence Resonance Energy Transfer - ScienceDirect

The Structure of Apolipoprotein A-I in High Density Lipoproteins* - Journal  of Biological Chemistry
The Structure of Apolipoprotein A-I in High Density Lipoproteins* - Journal of Biological Chemistry

The apoB/apoA-I Ratio is a Strong Predictor of Cardiovascular Risk |  IntechOpen
The apoB/apoA-I Ratio is a Strong Predictor of Cardiovascular Risk | IntechOpen

Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL |  SpringerLink
Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL | SpringerLink

The apoB/apoA‐I ratio: a strong, new risk factor for cardiovascular disease  and a target for lipid‐lowering therapy – a review of the evidence -  WALLDIUS - 2006 - Journal of Internal Medicine -
The apoB/apoA‐I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid‐lowering therapy – a review of the evidence - WALLDIUS - 2006 - Journal of Internal Medicine -

Apolipoprotein A-I for Cardiac Recovery Post–Myocardial Infarction | JACC:  Basic to Translational Science
Apolipoprotein A-I for Cardiac Recovery Post–Myocardial Infarction | JACC: Basic to Translational Science

High‐density lipoprotein‐related cholesterol metabolism in Alzheimer's  disease - Pedrini - 2021 - Journal of Neurochemistry - Wiley Online Library
High‐density lipoprotein‐related cholesterol metabolism in Alzheimer's disease - Pedrini - 2021 - Journal of Neurochemistry - Wiley Online Library

Lipid-Sensing High-Throughput ApoA-I Assays - ScienceDirect
Lipid-Sensing High-Throughput ApoA-I Assays - ScienceDirect

Apolipoprotein A-I (ApoA-I) Mimetic Peptide P2a by Restoring Cholesterol  Esterification Unmasks ApoA-I Anti-Inflammatory Endogenous Activity In Vivo  | Journal of Pharmacology and Experimental Therapeutics
Apolipoprotein A-I (ApoA-I) Mimetic Peptide P2a by Restoring Cholesterol Esterification Unmasks ApoA-I Anti-Inflammatory Endogenous Activity In Vivo | Journal of Pharmacology and Experimental Therapeutics

Apolipoprotein AI - Wikipedia
Apolipoprotein AI - Wikipedia

HDL (High-Density Lipoprotein) and ApoA-1 (Apolipoprotein A-1) Potentially  Modulate Pancreatic α-Cell Glucagon Secretion | Arteriosclerosis,  Thrombosis, and Vascular Biology
HDL (High-Density Lipoprotein) and ApoA-1 (Apolipoprotein A-1) Potentially Modulate Pancreatic α-Cell Glucagon Secretion | Arteriosclerosis, Thrombosis, and Vascular Biology

Cancers | Free Full-Text | Apolipoprotein A-I (ApoA-I), Immunity,  Inflammation and Cancer
Cancers | Free Full-Text | Apolipoprotein A-I (ApoA-I), Immunity, Inflammation and Cancer

Schematic presentation of ApoA-I peptide interaction with lipids. (A)... |  Download Scientific Diagram
Schematic presentation of ApoA-I peptide interaction with lipids. (A)... | Download Scientific Diagram

Figure 3
Figure 3

Biomolecules | Free Full-Text | The Role of HDL and HDL Mimetic Peptides as  Potential Therapeutics for Alzheimer's Disease
Biomolecules | Free Full-Text | The Role of HDL and HDL Mimetic Peptides as Potential Therapeutics for Alzheimer's Disease

Therapies to Increase ApoA-I and HDL-Cholesterol Levels | Semantic Scholar
Therapies to Increase ApoA-I and HDL-Cholesterol Levels | Semantic Scholar

Cancers | Free Full-Text | Apolipoprotein A-I (ApoA-I), Immunity,  Inflammation and Cancer
Cancers | Free Full-Text | Apolipoprotein A-I (ApoA-I), Immunity, Inflammation and Cancer

The Interaction of ApoA-I and ABCA1 Triggers Signal Transduction Pathways  to Mediate Efflux of Cellular Lipids | Molecular Medicine | Full Text
The Interaction of ApoA-I and ABCA1 Triggers Signal Transduction Pathways to Mediate Efflux of Cellular Lipids | Molecular Medicine | Full Text

Dietary Strategies and Novel Pharmaceutical Approaches Targeting Serum ApoA- I Metabolism: A Systematic Overview
Dietary Strategies and Novel Pharmaceutical Approaches Targeting Serum ApoA- I Metabolism: A Systematic Overview

HDL-apoA-I Exchange: Rapid Detection and Association with Atherosclerosis |  PLOS ONE
HDL-apoA-I Exchange: Rapid Detection and Association with Atherosclerosis | PLOS ONE

ApoA-I reduces inflammation in the CNS by preventing contact between... |  Download Scientific Diagram
ApoA-I reduces inflammation in the CNS by preventing contact between... | Download Scientific Diagram

HDL-apoA-I Exchange: Rapid Detection and Association with Atherosclerosis |  PLOS ONE
HDL-apoA-I Exchange: Rapid Detection and Association with Atherosclerosis | PLOS ONE

Molecular basis for a novel systemic form of human hereditary apoA-I  amyloidosis with vision loss | bioRxiv
Molecular basis for a novel systemic form of human hereditary apoA-I amyloidosis with vision loss | bioRxiv